Pilomatrixoma
Key Points
Pilomatrixoma is a benign tumor of the hair follicle
It occurs in any hair-bearing areas of the body, most often in the skin of the head and neck
The pathogenesis remains unknown, but it has been suggested that pilomatrixoma may develop from sequestered epidermal elements into abnormal locations during embryonic development or that it may arise from ectodermal tissue from the hair matrix
Clinically, periorbital pilomatrixomas present as slow-growing, solitary, asymptomatic, well-circumscribed, hard, mobile cutaneous masses
The treatment of choice is complete surgical resection, and malignant transformation is very rare
The prognosis is generally excellent following surgical resection, and recurrences are unusual
Pilomatrixoma, also known as pilomatricoma and calcifying epithelioma of Malherbe, is a benign tumor of the hair follicle. It was initially described by Malherbe and Chenantois in 1880 as a “calcified epithelioma,” believed to derive from the sebaceous gland.1 In 1949, Lever and Griesemer2 suggested an origin from the hair matrix cells.
Pilomatrixoma can occur in any hair-bearing area of the body, although it occurs most often in the skin of the head and neck.3,4 In the periorbital skin it arises from the matrix cells at the base of the eyelids and the eyebrows.5 Although it can be seen in patients from infancy to old age, it is far more common in the first 2 decades of life. Sixty percent of cases arise before the age of 10 years,6,7,8 and 75% occur in patients 20 years or younger.9 Some studies have reported little or no gender difference,10,11 but most have demonstrated a clear female predominance,12,13,14,15 with a female to male ratio of 2:1 to 3:1.9,16,17 The most common site of occurrence is the head and neck (51.8%), followed by lesions on the extremities (37.7%) and trunk (10.5%)7,18 and other rare sites such as the middle ear.19 Malignant transformation is rare but has been described, with metastasis to regional lymph nodes, the lung, brain, bones, and visceral organs.9,20,21 Familial cases have also been observed,18,20,22 sometimes in association with systemic syndromes. Lesions are typically single, and multiple pilomatrixomas are rare.23,24,25 When multiple lesions are seen it should raise suspicion for related systemic disorders such as myotonic dystrophy,26 Churg-Strauss syndrome,27 Gardner syndrome,28 trisomy 9,29 Rubinstein-Taybi syndrome,30 xeroderma pigmentosum,31 and sarcoidosis.32
Etiology and Pathogenesis
The exact pathogenesis of pilomatrixoma remains unknown. Some authors have suggested that pilomatrixoma may develop from sequestered epidermal elements into abnormal locations during embryonic development.19,42 Lever and Griesemer2 considered pilomatrixoma to be a hamartoma, and Dubreuilh and Cazenave43 proposed pilomatrixomas arise from ectodermal tissue consistent with their origin from the hair matrix.
Several studies have demonstrated mutations in the Wnt signaling pathway and altered protooncogene expression in basophilic and shadow cells.38,44 Other studies have demonstrated mutations in the CTNNB1 gene (3q22), which encodes beta-catenin,45 a downstream effector in the Wnt signaling pathway that affects multiple cellular processes, including cell differentiation into the hair follicle and cell proliferation.44 Mutations of this gene result in an upregulation of intracytoplasmic and intranuclear beta-catenin leading to the development of neoplasms of hair matrix differentiation.11,44 Associations between pilomatrixoma and several genetic diseases, such as Gardner syndrome, Rubinstein-Taybi syndrome, Sotos syndrome, myotonic dystrophy, and Turner syndrome suggest abnormalities in other cell signaling pathways as well.11,26,46
Clinical Characteristics
Clinically, periorbital pilomatrixomas present as slow-growing, solitary, asymptomatic, well-circumscribed, hard, mobile cutaneous masses (Figure 102.1).12,13,14,15,47 They can be multiple in up to 4% of cases.18,25,48 The overlying skin may be normal or show a red to blue coloration,7,16 and rarely, there may be areas of surface ulceration (Figure 102.2).49,50,51 Lesions can range from 4 mm to 2.5 cm. Occasionally, lesions can show rapid growth after surgical trauma.52 About 65% involve the eyebrow (Figure 102.3), 28% the upper eyelid, 5% the lower eyelid,
and 1.5% the medial canthus.16 About one-third show some calcification, and 1% are ossified.53,54
and 1.5% the medial canthus.16 About one-third show some calcification, and 1% are ossified.53,54